Eli Lilly’s Verzenio Picks Up Third Approved Indication Post author:Sam Post published:February 26, 2018 Post category:BioPharma Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace You Might Also Like Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016 March 26, 2017 Dova Pharma Announces Pricing Of Initial Public Offering June 28, 2017 Flagship Biosciences, Inc. Release: Is PD-L1 Harmonization On The Horizon? March 21, 2017
Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016 March 26, 2017
